Wellcome Trust – Impact of vaccines on antimicrobial resistance

The Wellcome Trust invites expressions of interest for its impact of vaccines on antimicrobial resistance scheme.

This supports researchers investigating the impact of vaccines on antibiotic use and antimicrobial resistance with the aim of informing vaccine decision-makers around the world and tackling antimicrobial resistance. Projects must aim to analyse data on antimicrobial resistance or antibiotic use in the context of a vaccine study. They may analyse existing data or collect and analyse new data from an ongoing or planned vaccine study. Data may include antibiotic use, drug-resistant infections, antibiotic prescribing behaviour and antibiotic seeking behaviour. Researchers can work on vaccines that are marketed or in development, targeting pathogens that are becoming more difficult to treat with antibiotics and cause symptoms that drive antibiotic use. These may include vaccines against:

  • Streptococcus pneumoniae;
  • Haemophilus influenzae,
  • Salmonella typhi;
  • Rotavirus;
  • Influenza;
  • Malaria.

Individuals or teams of up to seven people from anywhere in the world may apply. Applicants must be based at an academic research organisation, a non-profit or private sector organisation, or a government body.

Small awards are worth up to £250,000 and large awards are worth between £250,000 and £750,000.

Funding may support: staff; materials and consumables; equipment; access charges; research management and support; travel and subsistence; fieldwork; open access charges; other costs.

The duration of the programme is flexible and dependent on the level of funding.

Deadline: 6th September 2019.

Torna in alto